Skip to main content

Characterizing Pluripotent Stem Cells Using the TaqMan® hPSC ScorecardTM Panel

  • Protocol
  • First Online:
Book cover Human Embryonic Stem Cell Protocols

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1307))

Abstract

Rapid technological developments for the efficient generation of footprint-free induced pluripotent stem cells (iPSC) enabled the creation of patient-specific iPSC for downstream applications in drug discovery and regenerative medicine. However, the large number of iPSCs, generated from diverse genetic backgrounds using various methods and culture conditions, created a steep challenge for rapid characterization and a demand for standardized methods. Current methods rely on a combination of in vitro and in vivo cellular analyses based on the expression of markers of self-renewal and the ability of the cells to differentiate into cell types representative of the three germ layers as a confirmation of functional pluripotency. These methods, though informative and extensively used, are not ideal for parallel analyses of large numbers of samples and hence not amenable to high-throughput environments. Recently, genetic and epigenetic expression signatures were used to define and confirm cell states, thus providing a surrogate molecular assay that can potentially replace complex in vivo cellular assays such as teratoma formation.

In this chapter, we describe a molecular assay for rapid characterization and standardization of pluripotent stem cells. The TaqMan® hPSC Scorecard™ Panel is a comprehensive gene expression real-time PCR assay that consists of 94 individual q-PCR assays comprised of a combination of control, housekeeping, self-renewal, and lineage-specific genes. The resulting expression data set is analyzed using cloud-based analysis software that compares the expression pattern against a reference standard composed of multiple functionally validated ESC and iPSC lines. This system was successfully used to test several ESC and iPSC lines in their undifferentiated states to confirm their signatures of self renewal, as well as their terminally differentiates states, via spontaneous differentiation and directed differentiation into specific lineages, to determine the lines’ differentiation potential. This genetic analysis tool, together with the flexibility to utilize varying sample inputs and preparation methods, provides a rapid method to confirm functional pluripotency of ESCs and iPSCs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Maherali N, Hochedlinger K (2008) Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3:595–605

    Article  CAS  PubMed  Google Scholar 

  2. Malik N, Rao MS (2013) A review of the methods for human iPSC derivation. Methods Mol Biol 997:23–33

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Ko HC, Gelb BD (2014) Concise review: drug discovery in the age of the induced pluripotent stem cell. Stem Cells Transl Med 3:500–509

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Rao M, Gottesfeld JM (2014) Introduction to thematic minireview series: development of human therapeutics based on induced pluripotent stem cell (iPSC) technology. J Biol Chem 289:4553–4554

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Marti M, Mulero L, Pardo C et al (2013) Characterization of pluripotent stem cells. Nat Protoc 8:223–253

    Article  CAS  PubMed  Google Scholar 

  6. Wesselschmidt RL (2011) The teratoma assay: an in vivo assessment of pluripotency. Methods Mol Biol 767:231–241

    Article  CAS  PubMed  Google Scholar 

  7. Gertow K, Przyborski S, Loring JF et al (2007) Isolation of human embryonic stem cell-derived teratomas for the assessment of pluripotency. Curr Protoc Stem Cell Biol. Chapter 1:Unit1B 4

    Google Scholar 

  8. Muller FJ, Goldmann J, Loser P et al (2010) A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell 6:412–414

    Article  CAS  PubMed  Google Scholar 

  9. Daley GQ, Lensch MW, Jaenisch R et al (2009) Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell 4:200–201, author reply 202

    Article  CAS  PubMed  Google Scholar 

  10. Muller FJ, Schuldt BM, Williams R et al (2011) A bioinformatic assay for pluripotency in human cells. Nat Methods 8:315–317

    Article  PubMed Central  PubMed  Google Scholar 

  11. Guenther MG, Frampton GM, Soldner F et al (2010) Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7:249–257

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Chin MH, Mason MJ, Xie W et al (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5:111–123

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Narsinh KH, Plews J, Wu JC (2011) Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins? Mol Ther 19:635–638

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Hu BY, Weick JP, Yu J et al (2010) Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A 107:4335–4340

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Narsinh KH, Sun N, Sanchez-Freire V et al (2011) Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J Clin Invest 121:1217–1221

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Feng Q, Lu SJ, Klimanskaya I et al (2010) Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28:704–712

    Article  PubMed  Google Scholar 

  17. Bock C, Kiskinis E, Verstappen G et al (2011) Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144:439–452

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Joanna Asprer for assistance with review of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Uma Lakshmipathy .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this protocol

Cite this protocol

Fergus, J., Quintanilla, R., Lakshmipathy, U. (2014). Characterizing Pluripotent Stem Cells Using the TaqMan® hPSC ScorecardTM Panel. In: Turksen, K. (eds) Human Embryonic Stem Cell Protocols. Methods in Molecular Biology, vol 1307. Humana Press, New York, NY. https://doi.org/10.1007/7651_2014_109

Download citation

  • DOI: https://doi.org/10.1007/7651_2014_109

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2667-1

  • Online ISBN: 978-1-4939-2668-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics